Age-Related Macular Degeneration Bill

To make provision for the treatment of age-related macular degeneration; and for connected purposes.

Originating House

House of Commons

Last Updated

1 November 2007

In Plain English

AI-generated

This bill would make provision for the treatment of age-related macular degeneration (AMD) and for related purposes. In plain terms, it aims to help people with AMD access treatment and sets out related arrangements for care.

Key Points

Makes provision for the treatment of age-related macular degeneration (AMD).
Aims to improve access to AMD treatment and related care.
Covers connected purposes and associated provisions for delivery and administration.
There is one Amendment Paper published, indicating proposed changes will be considered.

Progress

The bill is currently at the second reading in the House of Commons. If it progresses, it will move to the committee stage for detailed consideration.

Who is affected?

People with age-related macular degenerationTheir families and carersOphthalmologists, optometrists and other eye health professionalsNHS and other healthcare providers involved in AMD treatmentPublic health bodies and policymakers involved in eye care

Generated 21 February 2026

Updates & Documents

Documents (1)

Marshalled List of Amendments as at 29 October 2007

Amendment PaperLords

29 Oct 2007

Parliamentary Votes (0)

No recorded votes for this bill yet.